574013-66-4,MFCD09971007
Catalog No.:AA0038JM

574013-66-4 | methyl (2E)-3-{3-[N-({4-[4-(dimethylamino)phenyl]phenyl}methyl)cyclohexaneamido]phenyl}prop-2-enoate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$46.00   $32.00
- +
25mg
98%
in stock  
$132.00   $93.00
- +
100mg
98%
in stock  
$393.00   $275.00
- +
250mg
98%
in stock  
$918.00   $643.00
- +
1g
98%
in stock  
$2,753.00   $1,927.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0038JM
Chemical Name:
methyl (2E)-3-{3-[N-({4-[4-(dimethylamino)phenyl]phenyl}methyl)cyclohexaneamido]phenyl}prop-2-enoate
CAS Number:
574013-66-4
Molecular Formula:
C32H36N2O3
Molecular Weight:
496.6398
MDL Number:
MFCD09971007
SMILES:
COC(=O)/C=C/c1cccc(c1)N(C(=O)C1CCCCC1)Cc1ccc(cc1)c1ccc(cc1)N(C)C
Properties
Computed Properties
 
Complexity:
743  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
1  
Formal Charge:
0  
Heavy Atom Count:
37  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
9  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
6.9  

Literature

Title: Discovery of new non-steroidal FXR ligands via a virtual screening workflow based on Phase shape and induced fit docking.

Journal: Bioorganic & medicinal chemistry letters 20121115

Title: [Progress in the ligands and their complex structures of farnesoid X receptor].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20120601

Title: Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP).

Journal: American journal of physiology. Gastrointestinal and liver physiology 20090701

Title: The farnesoid X receptor FXRalpha/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution.

Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20070901

Title: 3D-QSAR studies with the aid of molecular docking for a series of non-steroidal FXR agonists.

Journal: Bioorganic & medicinal chemistry letters 20070415

Title: The farnesoid X receptor: a novel drug target?

Journal: Expert opinion on investigational drugs 20040901

Title: A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.

Journal: Molecular cell 20030401

Title: N-hydroxyamobarbital: the second major metabolite of amobarbital in man.

Journal: Drug metabolism and disposition: the biological fate of chemicals 19750101

Title: Lam IP, et al. Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP). Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G90-7.

Title: Michael Downes, et al. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell. 2003 Apr;11(4):1079-92.

Title: Fang S, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med. 2015 Feb;21(2):159-65.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 574013-66-4
Tags:574013-66-4 Molecular Formula|574013-66-4 MDL|574013-66-4 SMILES|574013-66-4 methyl (2E)-3-{3-[N-({4-[4-(dimethylamino)phenyl]phenyl}methyl)cyclohexaneamido]phenyl}prop-2-enoate
Catalog No.: AA0038JM
574013-66-4,MFCD09971007
574013-66-4 | methyl (2E)-3-{3-[N-({4-[4-(dimethylamino)phenyl]phenyl}methyl)cyclohexaneamido]phenyl}prop-2-enoate
Pack Size: 1mg
Purity: ≥98%
in stock
$46.00 $32.00
Pack Size: 25mg
Purity: 98%
in stock
$132.00 $93.00
Pack Size: 100mg
Purity: 98%
in stock
$393.00 $275.00
Pack Size: 250mg
Purity: 98%
in stock
$918.00 $643.00
Pack Size: 1g
Purity: 98%
in stock
$2,753.00 $1,927.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0038JM
Chemical Name: methyl (2E)-3-{3-[N-({4-[4-(dimethylamino)phenyl]phenyl}methyl)cyclohexaneamido]phenyl}prop-2-enoate
CAS Number: 574013-66-4
Molecular Formula: C32H36N2O3
Molecular Weight: 496.6398
MDL Number: MFCD09971007
SMILES: COC(=O)/C=C/c1cccc(c1)N(C(=O)C1CCCCC1)Cc1ccc(cc1)c1ccc(cc1)N(C)C
Properties
Complexity: 743  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 1  
Formal Charge: 0  
Heavy Atom Count: 37  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 9  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 6.9  
Literature fold

Title: Discovery of new non-steroidal FXR ligands via a virtual screening workflow based on Phase shape and induced fit docking.

Journal: Bioorganic & medicinal chemistry letters20121115

Title: [Progress in the ligands and their complex structures of farnesoid X receptor].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica20120601

Title: Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP).

Journal: American journal of physiology. Gastrointestinal and liver physiology20090701

Title: The farnesoid X receptor FXRalpha/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution.

Journal: American journal of physiology. Regulatory, integrative and comparative physiology20070901

Title: 3D-QSAR studies with the aid of molecular docking for a series of non-steroidal FXR agonists.

Journal: Bioorganic & medicinal chemistry letters20070415

Title: The farnesoid X receptor: a novel drug target?

Journal: Expert opinion on investigational drugs20040901

Title: A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.

Journal: Molecular cell20030401

Title: N-hydroxyamobarbital: the second major metabolite of amobarbital in man.

Journal: Drug metabolism and disposition: the biological fate of chemicals19750101

Title: Lam IP, et al. Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP). Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G90-7.

Title: Michael Downes, et al. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell. 2003 Apr;11(4):1079-92.

Title: Fang S, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med. 2015 Feb;21(2):159-65.

Building Blocks More >
49674-16-0
49674-16-0
3-Amino-5-bromobenzonitrile
AA0038MS | MFCD11109874
3515-93-3
3515-93-3
4-Oxobutanenitrile
AA0038PY | MFCD00797978
21550-48-1
21550-48-1
6-Acetamidonicotinic acid
AA0038TA | MFCD11046979
112253-70-0
112253-70-0
2-Amino-4-bromobenzamide
AA0038WC | MFCD12674809
134052-73-6
134052-73-6
(S)-4-(Amino(carboxy)methyl)benzoic acid
AA0038ZN | MFCD00216831
886851-37-2
886851-37-2
2-(2-Bromophenoxy)-N,N-dimethylethanamine oxalate
AA00393K | MFCD03719321
1092961-01-7
1092961-01-7
6-(Bromomethyl)-1-methyl-1h-indazole
AA00397L | MFCD11052616
606143-89-9
606143-89-9
Mek162
AA0039B3 | MFCD22124525
924304-74-5
924304-74-5
5-(Trifluoromethyl)isoindoline hydrochloride
AA0039EP | MFCD10700142
86408-72-2
86408-72-2
sodium (4bS,8R,8aR)-8-carboxy-4b,8-dimethyl-2-(propan-2-yl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-3-sulfonate
AA0039IC | MFCD26131248
Submit
© 2017 AA BLOCKS, INC. All rights reserved.